home > drugs a-z list > besivance (besifloxacin ophthalmic suspension) drug center > besivance (besifloxacin ophthalmic suspension) drug - medication guide and patient information

Patients should be advised to avoid contaminating the applicator tip with material from the eye, fingers or other source.

Although Besivance™ (besifloxacin ophthalmic suspension) is not intended to be administered systemically, quinolones administered systemically have been associated with hypersensitivity reactions, even following a single dose.

Patients should be advised to discontinue use immediately and contact their physician at the first sign of a rash or allergic reaction.

Patients should be told that although it is common to feel better early in the course of the therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by Besivance™ (besifloxacin ophthalmic suspension) or other antibacterial drugs in the future.

Patients should be advised not to wear contact lenses if they have signs or symptoms of bacterial conjunctivitis or during the course of therapy with Besivance™ (besifloxacin ophthalmic suspension) .

Patients should be advised to thoroughly wash hands prior to using Besivance™ (besifloxacin ophthalmic suspension) .

Patients should be instructed to invert closed bottle (upside down) and shake once before each use. Remove cap with bottle still in the inverted position. Tilt head back, and with bottle inverted, gently squeeze bottle to instill one drop into the affected eye(s).

Last reviewed on RxList: 6/11/2009
This monograph has been modified to include the generic and brand name in many instances.